KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Asset Utilization Ratio (2016 - 2025)

West Pharmaceutical Services' Asset Utilization Ratio history spans 16 years, with the latest figure at 0.75 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 6.72% year-over-year to 0.75; the TTM value through Sep 2025 reached 0.75, down 6.72%, while the annual FY2024 figure was 0.77, 2.27% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.75 at West Pharmaceutical Services, down from 0.78 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.89 in Q2 2021 and bottomed at 0.75 in Q3 2025.
  • The 5-year median for Asset Utilization Ratio is 0.8 (2024), against an average of 0.82.
  • The largest annual shift saw Asset Utilization Ratio increased 9.83% in 2021 before it decreased 11.89% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.88 in 2021, then fell by 5.06% to 0.83 in 2022, then decreased by 6.59% to 0.78 in 2023, then grew by 1.64% to 0.79 in 2024, then fell by 5.27% to 0.75 in 2025.
  • Per Business Quant, the three most recent readings for WST's Asset Utilization Ratio are 0.75 (Q3 2025), 0.78 (Q2 2025), and 0.8 (Q1 2025).